ESC 365 - Genetic screening in dilated and non-dilated cardiomyopathy: should we broaden our perspective?

HFA Premium Access

Genetic screening in dilated and non-dilated cardiomyopathy: should we broaden our perspective?

Session: Young Investigator Award: Clinical

Topic: Dilated cardiomyopathy

Speaker: Mr M. Hazebroek (Maastricht, NL)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Mr Mark Hazebroek

Academic Hospital Maastricht, Maastricht (Netherlands (The))

0 follower

5 more presentations in this session

Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

Speaker: Miss J. Ter Maaten (Groningen, NL)

Prognostic burden of heart failure diagnosed in primary care or secondary care: a population-based linked electronic health record cohort study in 2.1 million people

Speaker: Doctor S. Koudstaal (Gouda, NL)

Treatment with insulin increases mortality in diabetic patients with chronic heart failure: data from the GISSI-HF Trial.

Speaker: Doctor D. Cosmi (Perugia, IT)

Renal venous pattern: a new parameter for predicting cardiorenal syndrome progression

Speaker: Doctor F. Monitillo (Pavia, IT)

The metabolic exercise cardiac and kidney indexes (mecki) score: a new prognostic tool in patients with heart failure. a multicenter comparison with seattle and hfss in a large cohort of patients

Speaker: Doctor M. Mapelli (Milan, IT)

Access the full session

Young Investigator Award: Clinical

Speakers: Mr M. Hazebroek, Miss J. Ter Maaten, Doctor S. Koudstaal, Doctor D. Cosmi, Doctor F. Monitillo...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources